Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study Options for single-agent ...

Overexpression of epidermal growth factor receptor (EGFR) has been associated with aggressive tumor phenotypes, chemotherapy, and radiation resistance, as well as poor survival in preclinical and ...

During the past few years, six clinical trials have been published on the treatment of advanced or metastatic gastric and gastroesophageal cancer using the combination capecitabine and irinotecan. [54 ...

Your doctor may prescribe Xeloda for 6 months. Or they may prescribe the drug longer than that. This depends on your cancer type and how your body responds to the drug. As with other drugs, Xeloda can ...

JoEllen Zembruski-Ruple, while in the care of New York City’s renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan.

Recent study results showed that patients with advanced HER2-positive breast cancer lived longer without disease progression when treated with Enhertu compared to when treated with Xeloda. Patients ...

Xeloda (capecitabine) has potential interactions with other medications and some supplements. For example, Xeloda can interact with warfarin (Jantoven) and celecoxib (Celebrex). Xeloda is used in ...

Should patients with metastatic colorectal cancer (CRC) who respond to first-line treatment receive maintenance therapy or are they better off on active surveillance? In a recent trial designed to ...

Xeloda (capecitabine) is a brand-name drug prescribed for certain forms of cancer. Xeloda comes as an oral tablet that’s taken for 2 weeks at a time. The dosage varies depending on what condition the ...

If you have certain kinds of cancer, your doctor might suggest Xeloda as a treatment option. It’s a prescription drug used to treat the following types of cancer in adults: Xeloda is also used to ...